Alucent Medical, Inc. is a biotech company focused on developing a novel drug-device combination therapy, NVS, to treat peripheral vascular disease. Our innovative approach leverages the body's natural healing process to restore blood flow and improve patient outcomes.
Headquarter United States of America |
Countries of operation Australia, United States of America |
Year founded 2017 (7 years) |
Funding status Series B |
Company type SME |
Clinical Field Specialist